Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
American Heart Journal|December 13, 2005
Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV TrialAmir Halkin, Roxana Mehran, Christopher W Casey, et al.Digital Health|March 19, 2025
Virtually assisted home rehabilitation after acute stroke (VAST-rehab): A descriptive pilot study for young and underserved stroke survivorsEmily A Stevens, Neha Muraly, Carolyn P Da Silva, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trialMark A Turco, Maurice Buchbinder, Jeffrey J Popma, et al.Journal of Medicinal Chemistry|June 13, 2003
1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic propertiesEdwin B Villhauer, John A Brinkman, Goli B Naderi, et al.Journal of Medicinal Chemistry|May 31, 2002
1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic propertiesEdwin B Villhauer, John A Brinkman, Goli B Naderi, et al.The American Journal of Cardiology|August 16, 2005
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy)Paul S Teirstein, John Kao, Matthew Watkins, et al.Journal of the American College of Cardiology|April 20, 2005
Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trialJames B Hermiller, Albert Raizner, Louis Cannon, et al.The American Journal of Cardiology|October 10, 2006
Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM Registry)Alexandre Abizaid, Charles Chan, Yean-Teng Lim, et al.Journal of the American College of Cardiology|April 20, 2005
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trialJeffrey W Moses, Roxana Mehran, Eugenia Nikolsky, et al.The American Journal of Cardiology|October 29, 2005
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study)Issam Moussa, Stephen G Ellis, Michael Jones, et al.Pageof 6